Skip to main content
. 2019 Jul 22;17:81. doi: 10.1186/s12964-019-0396-5

Fig. 1.

Fig. 1

High doses of TNTL possessed hypoglycemic effects. a. showed that TNTL treatment did not significantly change the body weight of hyperglycemic mice; b. showed that TNTL dose-dependently suppressed the increase of random blood glucose (RBG) by week; c. showed that TNTL dose-dependently reduced fasting blood glucose (FBG) after 4-week treatment; d. showed that medium and high doses of TNTL improved the glucose tolerance in hyperglycemic mice; e. showed that TNTL at medium and high doses can significantly reduce serum HbA1c levels. *p < 0.05, **p < 0.01, ***p < 0.001 when compared with model group